SILK RD MED INC's ticker is SILK and the CUSIP is 82710M100. A total of 156 filers reported holding SILK RD MED INC in Q1 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,615,445 | -30.1% | 80,500 | -15.8% | 0.44% | -39.4% |
| Q1 2023 | $3,740,398 | -16.3% | 95,589 | +13.0% | 0.72% | -16.9% |
| Q4 2022 | $4,470,529 | -12.9% | 84,589 | -25.8% | 0.86% | -14.4% |
| Q3 2022 | $5,130,000 | -37.8% | 114,000 | -49.7% | 1.01% | -39.2% |
| Q2 2022 | $8,252,000 | -4.4% | 226,764 | +8.5% | 1.66% | +8.6% |
| Q1 2022 | $8,630,000 | -3.1% | 209,000 | 0.0% | 1.53% | +14.3% |
| Q4 2021 | $8,905,000 | -61.9% | 209,000 | -50.8% | 1.34% | -31.0% |
| Q3 2021 | $23,360,000 | -7.2% | 424,500 | +6.3% | 1.94% | +9.6% |
| Q4 2020 | $25,159,000 | -3.5% | 399,483 | +3.0% | 1.77% | -20.9% |
| Q3 2020 | $26,076,000 | +19.2% | 387,983 | -25.7% | 2.24% | +11.7% |
| Q2 2020 | $21,876,000 | +216.7% | 522,228 | +138.0% | 2.01% | +51.4% |
| Q1 2020 | $6,907,000 | +0.5% | 219,400 | +28.9% | 1.33% | +29.2% |
| Q4 2019 | $6,873,000 | – | 170,200 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 399,483 | $25,159,000 | 1.77% |
| NEXT CENTURY GROWTH INVESTORS LLC | 313,534 | $19,746,000 | 1.66% |
| Graticule Asia Macro Advisors LLC | 52,565 | $3,311,000 | 1.59% |
| Bullseye Asset Management LLC | 58,112 | $3,659,000 | 1.36% |
| EMC Capital Management | 24,598 | $1,549,000 | 1.18% |
| Parkman Healthcare Partners LLC | 67,854 | $4,273,000 | 1.10% |
| Nicholas Investment Partners, LP | 219,483 | $13,823,000 | 1.07% |
| SCHOLTZ & COMPANY, LLC | 37,517 | $2,363,000 | 0.92% |
| WASATCH ADVISORS LP | 2,630,013 | $165,638,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 125,000 | $7,873,000 | 0.64% |